Fosun International’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-233,841
| Closed | -$6.54M | – | 225 |
|
|
2021
Q1 | $6.54M | Hold |
233,841
| – | – | 0.51% | 28 |
|
|
2020
Q4 | $6.63K | Hold |
233,841
| – | – | 0.43% | 30 |
|
|
2020
Q3 | $5.88M | Sell |
233,841
-210,000
| -47% | -$5.28M | 0.52% | 30 |
|
|
2020
Q2 | $10.8M | Sell |
443,841
-25,491
| -5% | -$623K | 1.04% | 19 |
|
|
2020
Q1 | $6.95M | Sell |
469,332
-3,200
| -0.7% | -$47.4K | 0.68% | 25 |
|
|
2019
Q4 | $7.67M | Hold |
472,532
| – | – | 0.64% | 23 |
|
|
2019
Q3 | $6.14M | Hold |
472,532
| – | – | 0.68% | 22 |
|
|
2019
Q2 | $6.13M | Hold |
472,532
| – | – | 0.4% | 38 |
|
|
2019
Q1 | $7.45M | Hold |
472,532
| – | – | 0.47% | 33 |
|
|
2018
Q4 | $9.51M | Hold |
472,532
| – | – | 0.57% | 29 |
|
|
2018
Q3 | $11.7M | Hold |
472,532
| – | – | 0.56% | 26 |
|
|
2018
Q2 | $13M | Buy |
472,532
+153,219
| +48% | +$4.21M | 0.66% | 33 |
|
|
2018
Q1 | $9.84M | Buy |
+319,313
| New | +$9.84M | 0.62% | 34 |
|